Karyopharm to present at b. riley securities oncology investor conference

Newton, mass., jan. 21, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq:kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that richard paulson, president and chief executive officer of karyopharm, will present virtually at the b.
KPTI Ratings Summary
KPTI Quant Ranking